Mallinckrodt plc Files 8-K/A Amendment
| Field | Detail |
|---|---|
| Company | Mallinckrodt PLC |
| Form Type | 8-K/A |
| Filed Date | Oct 16, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Mallinckrodt filed an amendment to its 8-K, check the details.
AI Summary
Mallinckrodt plc filed an 8-K/A on October 16, 2025, to amend a previous filing related to financial statements and exhibits as of July 31, 2025. The company, incorporated in Ireland, is based in Dublin and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed by Mallinckrodt plc.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, not indicating new material events or financial distress.
Key Numbers
- 001-35803 — SEC File Number (Identifies the company's filings with the SEC.)
- 98-1088325 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Mallinckrodt plc (company) — Registrant
- July 31, 2025 (date) — Reporting period end date
- October 16, 2025 (date) — Filing date
- Ireland (location) — Jurisdiction of incorporation and principal executive offices
- Dublin 15 (location) — City and postal code of principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report, specifically concerning financial statements and exhibits as of July 31, 2025.
When was the original event reported or the period covered by the amendment?
The earliest event reported or the period covered by the amendment is July 31, 2025.
What is Mallinckrodt plc's jurisdiction of incorporation?
Mallinckrodt plc is incorporated in Ireland.
Where are Mallinckrodt plc's principal executive offices located?
Mallinckrodt plc's principal executive offices are located at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.
What is the SIC code for Mallinckrodt plc?
The Standard Industrial Classification (SIC) code for Mallinckrodt plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 935 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2025-10-16 16:32:18
Filing Documents
- mnk-20250731.htm (8-K/A) — 32KB
- ex231pwcconsentendoinc.htm (EX-23.1) — 2KB
- ex232pwcconsentendoplc.htm (EX-23.2) — 2KB
- mnkproformasalvare2025q2.htm (EX-99.3) — 730KB
- 0001628280-25-045222.txt ( ) — 946KB
- mnk-20250731.xsd (EX-101.SCH) — 2KB
- mnk-20250731_lab.xml (EX-101.LAB) — 22KB
- mnk-20250731_pre.xml (EX-101.PRE) — 13KB
- mnk-20250731_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (a) Financial statements of businesses or funds acquired The audited consolidated financial statements of Endo, Inc. (Successor) as of December 31, 2024 and for the year ended December 31, 2024, and of Endo International Plc (Predecessor) as of December 31, 2023, for the period from January 1, 2024 to April 23, 2024, and for the years ended December 31, 2023 and 2022, and the related notes thereto, required by Item 9.01(a) are filed as Exhibit 99.1 hereto and are incorporated herein by reference. The unaudited condensed consolidated financial statements of Endo, Inc. (Successor) as of June 30, 2025 and for the six months ended June 30, 2025 and 2024, and of Endo International plc (Predecessor) for the period from April 1, 2024 to April 23, 2024, and the related notes thereto, required by Item 9.01(a) are filed as Exhibit 99.2 hereto and are incorporated herein by reference. (b) Pro forma financial information. The unaudited pro forma condensed combined balance sheet of the Company as of June 27, 2025 and the unaudited pro forma condensed combined statements of operations of the Company for the six months ended June 27, 2025 and for the year ended December 27, 2024, in each case after giving effect to the Business Combination, are filed as Exhibit 99.3 hereto and incorporated herein by reference. (d) Exhibits Exhibit Number Exhibit 23.1 Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm (Endo, Inc.). 23.2 Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm (Endo International plc). 99.1 Audited consolidated financial statements of Endo, Inc. (Successor) as of December 31, 2024 and for the year ended December 31, 2024, and of Endo International Plc (Predecessor) as of December 31, 2023, for the period from January 1, 2024 to April 23, 2024, and for the years ended December 31, 2023 and 2022, and the related notes thereto (incorporated by refer
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MALLINCKRODT PLC (registrant) Date: October 16, 2025 By: /s/ Christiana Stamoulis Christiana Stamoulis President and Chief Financial Officer (Principal Financial Officer)